v3.26.1
Consolidated Statements of Changes in Equity (Deficit) - USD ($)
Pre-capitalization [member]
Issued capital [member]
Pre-capitalization [member]
Share premium [member]
Pre-capitalization [member]
Other reserves [member]
Pre-capitalization [member]
Retained earnings [member]
Pre-capitalization [member]
Post-recapitalized [member]
Issued capital [member]
Post-recapitalized [member]
Share premium [member]
Post-recapitalized [member]
Other reserves [member]
Post-recapitalized [member]
Retained earnings [member]
Post-recapitalized [member]
Issued capital [member]
 [1]
Share premium [member]
Other reserves [member]
Retained earnings [member]
Total
Balance at Mar. 31, 2024 $ 9,724 $ 59,023 $ (998,918) $ (930,171)                    
IfrsStatementLineItems [Line Items]                              
Loss for the year (2,064,334) (2,064,334)                   $ (2,064,334)
Fair value adjustment on loan from related party 134,193 134,193                    
Transfer of Ionic to IMC Brazil           $ 209 $ 209          
Incorporation of the Company           (9,724) 9,724          
Balance at Mar. 31, 2025 9,724 193,216 (3,063,252) (2,860,312) [1] 203,149 (3,063,252) (2,860,103)         (2,860,103)
IfrsStatementLineItems [Line Items]                              
Loss for the year           (3,157,133) (3,157,133)         (3,157,133)
Fair value adjustment on loan from related party           184,172 184,172          
Transfer of Ionic to IMC Brazil 209 209                    
Incorporation of the Company $ (9,724) $ 9,724                    
Grant of royalty option to related party           (2,348,000) (2,348,000)          
Issuance of shares           $ 1,087,486 $ 1,087,486          
Balance at Mar. 31, 2026                     $ 1,087,486 $ 387,321 $ (8,568,385) $ (7,093,578)
[1] The Company has 1,011 and 1,000 issued and fully paid shares at a par value of USD$0.0001 per share as of March 31, 2026 and 2025, respectively. The Company had total authorised shares of 500,000,000 at March 31, 2026.